| __timestamp | BioMarin Pharmaceutical Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 54823000000 |
| Thursday, January 1, 2015 | 152008000 | 76691000000 |
| Friday, January 1, 2016 | 209620000 | 87477000000 |
| Sunday, January 1, 2017 | 241786000 | 89052000000 |
| Monday, January 1, 2018 | 315264000 | 100745000000 |
| Tuesday, January 1, 2019 | 359466000 | 91915000000 |
| Wednesday, January 1, 2020 | 524272000 | 95905000000 |
| Friday, January 1, 2021 | 470515000 | 104442000000 |
| Saturday, January 1, 2022 | 483669000 | 104437000000 |
| Sunday, January 1, 2023 | 577065000 | 112009000000 |
| Monday, January 1, 2024 | 580235000 | 121134000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals and retail, understanding cost dynamics is crucial. BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc. offer a fascinating study in contrasts. From 2014 to 2023, BioMarin's cost of revenue surged by over 340%, reflecting its aggressive growth strategy in the biotech sector. In contrast, Walgreens Boots Alliance, a retail giant, maintained a steady increase, with costs rising by approximately 104% over the same period.
BioMarin's costs peaked in 2023, highlighting its commitment to innovation and expansion. Meanwhile, Walgreens' costs consistently climbed, reaching their zenith in 2024, underscoring its resilience in the retail market. Notably, 2024 data for BioMarin is missing, leaving room for speculation on its future trajectory.
These insights reveal the distinct paths of two industry leaders, each navigating their unique challenges and opportunities.
Cost Insights: Breaking Down Novartis AG and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Trends: Pfizer Inc. vs Walgreens Boots Alliance, Inc.
Gilead Sciences, Inc. vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
Walgreens Boots Alliance, Inc. vs MorphoSys AG: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.